The new approval allows increased RF power to be used and to target any part of the body during scanning. Moreover, taking account certain parameters and setting the implant into a proper mode, the DBS therapy can continue to be delivered while the patient is inside the MRI system. Thus, receiving DBS therapy during imaging we hope will help achieve improved scan quality by controlling muscle movement in patients with essential tremor, Parkinson’s, and other conditions that cause involuntary motion.